Piwocka O, Musielak M, Ampula K, Piotrowski I, Adamczyk B, Fundowicz M
Cancer Cell Int. 2024; 24(1):28.
PMID: 38212739
PMC: 10785493.
DOI: 10.1186/s12935-023-03190-4.
Tang G, Sun K, Ding G, Wu J
Int J Gen Med. 2023; 16:1437-1453.
PMID: 37114071
PMC: 10126726.
DOI: 10.2147/IJGM.S408854.
Krzysiek-Maczka G, Targosz A, Wrobel T, Paw M, Szczyrk U, Opila J
Am J Cancer Res. 2022; 12(3):1337-1371.
PMID: 35411238
PMC: 8984895.
Wu Y, Wang Z, Du Q, Zhu Z, Chen T, Xue Y
Evid Based Complement Alternat Med. 2022; 2022:9523071.
PMID: 35082907
PMC: 8786487.
DOI: 10.1155/2022/9523071.
Sala M, Ros M, Saltel F
Front Oncol. 2020; 10:1620.
PMID: 32984031
PMC: 7485352.
DOI: 10.3389/fonc.2020.01620.
Epigenetic Input Dictates the Threshold of Targeting of the Integrin-Dependent Pathway in Non-small Cell Lung Cancer.
Zhang Y, Cheng K, Xu B, Shi J, Qiang J, Shi S
Front Cell Dev Biol. 2020; 8:652.
PMID: 32793596
PMC: 7387701.
DOI: 10.3389/fcell.2020.00652.
Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy.
Zhang Y, Xie Z, Guo X, Xiao X, Xiong L
Oncol Lett. 2019; 18(3):2743-2755.
PMID: 31452752
PMC: 6704289.
DOI: 10.3892/ol.2019.10653.
Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D, Wu Y, Zhang B, Yang J, Liu Y, Li X
Int J Nanomedicine. 2019; 14:6179-6195.
PMID: 31447559
PMC: 6683963.
DOI: 10.2147/IJN.S202424.
β1 Integrin is essential for fascin-mediated breast cancer stem cell function and disease progression.
Barnawi R, Al-Khaldi S, Colak D, Tulbah A, Al-Tweigeri T, Fallatah M
Int J Cancer. 2019; 145(3):830-841.
PMID: 30719702
PMC: 6593770.
DOI: 10.1002/ijc.32183.
Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro.
Krzysiek-Maczka G, Targosz A, Szczyrk U, Strzalka M, Sliwowski Z, Brzozowski T
Helicobacter. 2018; 23(6):e12538.
PMID: 30246423
PMC: 6282800.
DOI: 10.1111/hel.12538.
YAP/TAZ Activation as a Target for Treating Metastatic Cancer.
Warren J, Xiao Y, Lamar J
Cancers (Basel). 2018; 10(4).
PMID: 29642615
PMC: 5923370.
DOI: 10.3390/cancers10040115.
Post-menopausal breast cancer: from estrogen to androgen receptor.
Majumder A, Singh M, Tyagi S
Oncotarget. 2017; 8(60):102739-102758.
PMID: 29254284
PMC: 5731994.
DOI: 10.18632/oncotarget.22156.
Organotypic three-dimensional assays based on human leiomyoma-derived matrices.
Salo T, Dourado M, Sundquist E, Apu E, Alahuhta I, Tuomainen K
Philos Trans R Soc Lond B Biol Sci. 2017; 373(1737).
PMID: 29158312
PMC: 5717437.
DOI: 10.1098/rstb.2016.0482.
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T, Prasad P, Cai P, He C, Shan D, Rauth A
Acta Pharmacol Sin. 2017; 38(6):835-847.
PMID: 28216624
PMC: 5520182.
DOI: 10.1038/aps.2016.166.
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes M, Shen X, Das S, Emdad L, Sarkar D, Fisher P
Oncotarget. 2016; 7(49):80175-80189.
PMID: 27863394
PMC: 5348312.
DOI: 10.18632/oncotarget.13373.
Divide or Conquer: Cell Cycle Regulation of Invasive Behavior.
Kohrman A, Matus D
Trends Cell Biol. 2016; 27(1):12-25.
PMID: 27634432
PMC: 5186408.
DOI: 10.1016/j.tcb.2016.08.003.
miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das S, Romagnoli M, Mineva N, Barille-Nion S, Jezequel P, Campone M
Breast Cancer Res. 2016; 18(1):40.
PMID: 27039296
PMC: 4818899.
DOI: 10.1186/s13058-016-0699-z.
Cancer metastases: challenges and opportunities.
Guan X
Acta Pharm Sin B. 2015; 5(5):402-18.
PMID: 26579471
PMC: 4629446.
DOI: 10.1016/j.apsb.2015.07.005.
Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.
Decarlo L, Mestel C, Barcellos-Hoff M, Schneider R
Mol Cell Biol. 2015; 35(15):2597-609.
PMID: 25986608
PMC: 4524117.
DOI: 10.1128/MCB.00324-15.
New mechanistic insights of integrin β1 in breast cancer bone colonization.
Thibaudeau L, Taubenberger A, Theodoropoulos C, Holzapfel B, Ramuz O, Straub M
Oncotarget. 2014; 6(1):332-44.
PMID: 25426561
PMC: 4381598.
DOI: 10.18632/oncotarget.2788.